711 related articles for article (PubMed ID: 33461503)
21. Lymphocyte Subset Alteration and Monocyte CD4 Expression Reduction in Patients with Severe COVID-19.
Kazancioglu S; Yilmaz FM; Bastug A; Sakallı A; Ozbay BO; Buyuktarakci C; Bodur H; Yilmaz G
Viral Immunol; 2021 Jun; 34(5):342-351. PubMed ID: 33264073
[TBL] [Abstract][Full Text] [Related]
22. Correlation Between Relative Nasopharyngeal Virus RNA Load and Lymphocyte Count Disease Severity in Patients with COVID-19.
Liu Y; Liao W; Wan L; Xiang T; Zhang W
Viral Immunol; 2021 Jun; 34(5):330-335. PubMed ID: 32297828
[TBL] [Abstract][Full Text] [Related]
23. Cytokines and Leukocytes Subpopulations Profile in SARS-CoV-2 Patients Depending on the CT Score Severity.
Rutkowska E; Kwiecień I; Żabicka M; Maliborski A; Raniszewska A; Kłos K; Urbańska W; Klajnowicz I; Rzepecki P; Chciałowski A
Viruses; 2021 May; 13(5):. PubMed ID: 34064802
[TBL] [Abstract][Full Text] [Related]
24. Dynamics of NK, CD8 and Tfh cell mediated the production of cytokines and antiviral antibodies in Chinese patients with moderate COVID-19.
Yan L; Cai B; Li Y; Wang MJ; An YF; Deng R; Li DD; Wang LC; Xu H; Gao XD; Wang LL
J Cell Mol Med; 2020 Dec; 24(24):14270-14279. PubMed ID: 33145962
[TBL] [Abstract][Full Text] [Related]
25. Apoptosis and immunophenotyping of peripheral blood lymphocytes in Iranian COVID-19 patients: Clinical and laboratory characteristics.
Taghiloo S; Aliyali M; Abedi S; Mehravaran H; Sharifpour A; Zaboli E; Eslami-Jouybari M; Ghasemian R; Vahedi-Larijani L; Hossein-Nattaj H; Amjadi O; Rezazadeh H; Ajami A; Asgarian-Omran H
J Med Virol; 2021 Mar; 93(3):1589-1598. PubMed ID: 32910458
[TBL] [Abstract][Full Text] [Related]
26. The clinical course and its correlated immune status in COVID-19 pneumonia.
He R; Lu Z; Zhang L; Fan T; Xiong R; Shen X; Feng H; Meng H; Lin W; Jiang W; Geng Q
J Clin Virol; 2020 Jun; 127():104361. PubMed ID: 32344320
[TBL] [Abstract][Full Text] [Related]
27. Early immune responses and prognostic factors in children with COVID-19: a single-center retrospective analysis.
Lu W; Yang L; Li X; Sun M; Zhang A; Qi S; Chen Z; Zhang L; Li J; Xiong H
BMC Pediatr; 2021 Apr; 21(1):181. PubMed ID: 33865340
[TBL] [Abstract][Full Text] [Related]
28. Lymphocyte subsets as a predictor of severity and prognosis in COVID-19 patients.
Zhang P; Du W; Yang T; Zhao L; Xiong R; Li Y; Geng Y; Lu W; Zhou J
Int J Immunopathol Pharmacol; 2021; 35():20587384211048567. PubMed ID: 34619994
[TBL] [Abstract][Full Text] [Related]
29. T cell counts and IL-6 concentration in blood of North African COVID-19 patients are two independent prognostic factors for severe disease and death.
Belaid B; Lamara Mahammad L; Mihi B; Rahali SY; Djidjeli A; Larab Z; Berkani L; Berkane I; Sayah W; Merah F; Lazli NZ; Kheddouci L; Kadi A; Ouali M; Khellafi R; Mekideche D; Kheliouen A; Ayoub S; Hamidi RM; Derrar F; Gharnaout M; Allam I; Djidjik R
J Leukoc Biol; 2022 Jan; 111(1):269-281. PubMed ID: 33527487
[TBL] [Abstract][Full Text] [Related]
30. The Quantitative and Functional Changes of Postoperative Peripheral Blood Immune Cell Subsets Relate to Prognosis of Patients with Subarachnoid Hemorrhage: A Preliminary Study.
Zhou Y; Jiang Y; Peng Y; Zhang M
World Neurosurg; 2017 Dec; 108():206-215. PubMed ID: 28866066
[TBL] [Abstract][Full Text] [Related]
31. Lessons Learned Comparing Immune System Alterations of Bacterial Sepsis and SARS-CoV-2 Sepsis.
Dong X; Wang C; Liu X; Gao W; Bai X; Li Z
Front Immunol; 2020; 11():598404. PubMed ID: 33329592
[TBL] [Abstract][Full Text] [Related]
32. Characteristics of immune cells and cytokines in patients with coronavirus disease 2019 in Guangzhou, China.
Chen X; Huang J; Huang Y; Chen J; Huang Y; Jiang X; Shi Y
Hum Immunol; 2020 Dec; 81(12):702-708. PubMed ID: 32950268
[TBL] [Abstract][Full Text] [Related]
33. Immune dysfunction following COVID-19, especially in severe patients.
Song CY; Xu J; He JQ; Lu YQ
Sci Rep; 2020 Sep; 10(1):15838. PubMed ID: 32985562
[TBL] [Abstract][Full Text] [Related]
34. Dynamic Changes of Lymphocyte Subsets in the Course of COVID-19.
Rezaei M; Marjani M; Mahmoudi S; Mortaz E; Mansouri D
Int Arch Allergy Immunol; 2021; 182(3):254-262. PubMed ID: 33498051
[TBL] [Abstract][Full Text] [Related]
35. Monitoring peripheral neutrophil and T-lymphocyte subsets could assist in differentiating the severity and disease progression of coronavirus disease 2019.
Meng L; Xu J; Zhang J; Zhang K; Shang P; Li Q; Li Y; Wang L; Cai B
Aging (Albany NY); 2021 Mar; 13(6):7723-7732. PubMed ID: 33741750
[TBL] [Abstract][Full Text] [Related]
36. The role of cytokine profile and lymphocyte subsets in the severity of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.
Akbari H; Tabrizi R; Lankarani KB; Aria H; Vakili S; Asadian F; Noroozi S; Keshavarz P; Faramarz S
Life Sci; 2020 Oct; 258():118167. PubMed ID: 32735885
[TBL] [Abstract][Full Text] [Related]
37. Deciphering the COVID-19 cytokine storm: Systematic review and meta-analysis.
Mulchandani R; Lyngdoh T; Kakkar AK
Eur J Clin Invest; 2021 Jan; 51(1):e13429. PubMed ID: 33058143
[TBL] [Abstract][Full Text] [Related]
38. Peripheral Inflammatory Cytokines and Lymphocyte Subset Features of Deceased COVID-19 Patients.
Jiang N; Li Z; Yang B; Jin M; Sun Y; He Y; Liu Y; Wang Y; Si D; Ma P; Zhang J; Liu T; Yu Q
Biomed Res Int; 2021; 2021():9101082. PubMed ID: 33542929
[TBL] [Abstract][Full Text] [Related]
39. Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia.
Wang F; Nie J; Wang H; Zhao Q; Xiong Y; Deng L; Song S; Ma Z; Mo P; Zhang Y
J Infect Dis; 2020 May; 221(11):1762-1769. PubMed ID: 32227123
[TBL] [Abstract][Full Text] [Related]
40. Lymphocyte subset alterations with disease severity, imaging manifestation, and delayed hospitalization in COVID-19 patients.
Wu D; Wu X; Huang J; Rao Q; Zhang Q; Zhang W
BMC Infect Dis; 2021 Jul; 21(1):631. PubMed ID: 34210280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
